Particle.news
Download on the App Store

France’s Drug Regulator Orders Halt to ‘GLP‑1’ Patch Sales on Seven Websites

The move follows tests finding the patches devoid of GLP‑1 drugs, enabling seizures by French customs.

Overview

  • ANSM imposed police‑sanitary measures that suspend marketing, distribution, import, export, holding for sale, and advertising of products falsely presented as aGLP‑1 treatments.
  • Seven targeted domains are operated by Hong Kong–based Hamjouy Limited and Zongest Limited, including clairezon.com, ethereallives.com, jourvefgrt.com, sainetbeau.com, slimsculed.com, raindewmen.com, and denanica.com.
  • French customs can now seize incoming shipments of these products, and the agency has referred the matter to judicial authorities.
  • ANSM laboratory analyses of marketed patches found no semaglutide, insulin, or other slimming actives, with warnings that some items misuse ANSM and EMA logos and may contain harmful substances.
  • After earlier alerts, Amazon, eBay, and Cdiscount removed listings, while the regulator says similar enforcement will follow for any newly reported sites; genuine GLP‑1 medicines remain prescription‑only via pharmacies.